Results 131 to 140 of about 41,988 (210)

Patient perspectives on antipsychotic treatments and their association with clinical outcomes

open access: yes, 2010
Hong Liu-Seifert1, Olawale O Osuntokun1, Jenna L Godfrey2, Peter D Feldman11Lilly Research Laboratories, Indianapolis, IN, USA; 2Durham Veterans Affairs Medical Center, Durham, NC, USAAbstract: This analysis examined patient-reported attitudes toward ...
Olawale O Osuntokun   +3 more
core  

Cognitive, Motor and Oculomotor Contributions to the Trail Making Test in Progressive Supranuclear Palsy

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Progressive supranuclear palsy (PSP) is a neurodegenerative disorder characterized by motor, oculomotor and cognitive impairments. Yet disentangling cognitive deficits from motor and oculomotor dysfunction remains a diagnostic and methodological challenge.
Indira Garcia‐Cordero   +12 more
wiley   +1 more source

The Coding-Synonymous Polymorphism Rs1045280 (Ser280ser) in Beta-Arrestin 2 (Arrb2) Gene Is Associated with Tardive Dyskinesia in Chinese Patients with Schizophrenia

open access: yes, 2011
Tardive dyskinesia (TD) is a severe and potentially irreversible adverse effect of long-term antipsychotic treatment. Typical antipsychotics are commonly binding to the dopamine receptor D2 (DRD2), but the occurrence of antipsychotic-induced TD is rather
LIOU, YING-JAY;WANG, YING-CHIEH;CHEN, JEN-YEU;BAI, YA-MEI;LIN, CHAO-CHENG;LIAO, DING-LIEH;LAI, I-CHING   +1 more
core  

Continuous Intrajejunal Levodopa–Carbidopa Infusion in Parkinson's Disease Associated with 22q11.2 Deletion Syndrome: A Case Series

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background 22q11.2 deletion syndrome (22q11DS) is a multisystem genetic disorder associated with a significantly increased risk of early‐onset Parkinson's disease (EOPD). Management is challenging because psychiatric and cognitive comorbidities often limit advanced therapies such as deep brain stimulation (DBS). Cases We report 2 patients with
Valle Victor Andrés   +10 more
wiley   +1 more source

Editorial: Rising stars in cellular neuropathology 2022

open access: yesFrontiers in Cellular Neuroscience
Christian Zammit   +2 more
doaj   +1 more source

Falls in Huntington's Disease: A Cross‐Sectional Analysis of Clinical Features and Potential Contributors

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Falls occur across all stages of Huntington's disease (HD) and are associated with poor quality of life and injury. However, there is limited information on falls in HD. Objective The aim was to investigate the clinical features potentially associated with falls in HD. Methods We conducted a cross‐sectional, analytical observational
Arthur Pena Ferreira   +5 more
wiley   +1 more source

Editorial: Safety and side effects of psychotropic medications, volume III

open access: yesFrontiers in Psychiatry
Renato de Filippis   +4 more
doaj   +1 more source

A comparison of cardiovascular risk factors for ten antipsychotic drugs in clinical practice

open access: yes, 2013
Robert Bodén,1,2 Gunnar Edman,3,4 Johan Reutfors,2 Claes-Göran Östenson,3 Urban Ösby3,4 1Department of Neuroscience, Psychiatry, Uppsala University, Uppsala, Sweden; 2Department of Medicine Solna, Centre for ...
Östenson CG   +4 more
core  

Should Paratonia Be Considered a Movement Disorder? Implications for Clinical Management

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Paratonia is an involuntary and variable resistance to passive movement that emerges with cognitive decline in dementias of different etiologies, with prevalence approaching 90% to 100% in end‐stage disease. It is common in Parkinson disease and the atypical parkinsonisms.
Galit Kleiner   +2 more
wiley   +1 more source

Dietary Fatty Acids, Cardiovascular Disease, and Life Expectancy Among Adults With Adverse Mental Health‐Related Characteristics: A Cohort‐Based Target Trial Emulation Study

open access: yesMed Research, EarlyView.
This study highlights the cardiovascular and longevity benefits of dietary n‐3 PUFAs in individuals with adverse mental health‐related characteristics, particularly ALA and EPA. The target trial emulation framework further provides evidence, revealing EPA and DHA are associated with a lower early‐onset CVD risk in loneliness, while ALA and EPA are ...
Li Chen   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy